The Science of Microdosing Psychedelics by Torsten Passie
The Science of Microdosing Psychedelics by Torsten Passie, with a preface by Dr David Nichols.
Paperback | ISBN 9780992808884
This is a pre-order: Due 10.2.2019
It has been claimed that microdosing psychedelic substances such as LSD has the ability to enhance creativity, elevate mood and even combat depression. In this new book, Torsten Passie MD, author of The Pharmacology of LSD (2010), delves into the first-wave scientific literature on microdosing. He reveals a rich and largely ignored history of research with microdose, minidose and low-dose LSD, and other psychedelics.
At a time when microdosing is being lauded across the media as a potential panacea, this carefully researched and scientifically presented work provides an objective and clear perspective, covering key areas such as tolerance, toxicity, and placebo. A book no discerning researcher, practitioner or psychedelic aficionado should be without, The Science of Microdosing Psychedelics is an invaluable enchiridion of information and insight.
"Finally, a book about microdose research I can recommend without reservation. Torsten Passie has written the definitive review of the effects of microdosing and mini-dosing (slightly more) LSD, including dozens of reports of early research, most never referenced before" - Microdosing researcher, Dr James Fadiman
Torsten Passie, MD: Between 1997-2010 Torsten was a scientist, psychiatrist and psychotherapist at Hannover Medical School, where he lead the Laboratory for Consciousness and Neurocognition. His research studies were on the psychophysiology of altered states of consciousness, including clinical studies with breathwork, cannabis, MDMA, laughing gas, ketamine and psilocybin. Special expertise on ecstatic states, addictions, the pharmacology of psychedelic substances and psycholytic therapy. Discovery of 2-Bromo-LSD, a non-hallucinogenic congener of LSD, for the treatment of cluster headache in 2008. From 2012 to 2015 visiting professor at the Department of Psychiatry of Harvard Medical School (Boston, USA).